David Johnson

Direktor/Vorstandsmitglied bei CARIBOU BIOSCIENCES, INC.

Vermögen: - $ am 31.05.2024

55 Jahre

Health Technology

Consumer Services

Aktive Positionen von David Johnson

Unternehmen	Position	Beginn	Ende
CARIBOU BIOSCIENCES, INC.	Direktor/Vorstandsmitglied	11.05.2022	-
CARIBOU BIOSCIENCES, INC.	Independent Dir/Board Member	11.05.2022	-

Unternehmen	Position	Beginn	Ende
GLOBAL BLOOD THERAPEUTICS, INC.	Corporate Officer/Principal	12.03.2018	01.12.2022
GILEAD SCIENCES, INC.	Vertrieb & Marketing	01.01.2003	01.01.2018

University of Puget Sound	Undergraduate Degree
Kenan-Flagler Business School	Masters Business Admin

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	1
Undergraduate Degree	1
Masters Business Admin	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
GILEAD SCIENCES, INC.	Health Technology
CARIBOU BIOSCIENCES, INC.	Health Technology

Private Unternehmen	1
Global Blood Therapeutics, Inc. Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.	Health Technology

Private Unternehmen

Health Technology